Guanze Medical Information Industry (Holding) Co., Ltd. (HKG:2427)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
1.560
0.00 (0.00%)
At close: Jan 26, 2026

HKG:2427 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
147.57155.74156.07177.11211.08184.44
Revenue Growth (YoY)
21.26%-0.21%-11.88%-16.09%14.45%30.97%
Cost of Revenue
93.2892.9570.6796.14135.38122.45
Gross Profit
54.2962.7985.4180.9875.761.98
Selling, General & Admin
28.7631.5740.932.5533.1920.84
Research & Development
4.834.071.530.540.41.19
Other Operating Expenses
-----0.79
Operating Expenses
34.0538.8346.733.2933.5122.94
Operating Income
20.2423.9538.747.6842.1939.05
Interest Expense
-0.74-0.71-0.86-1.03-0.6-0.79
Interest & Investment Income
0.170.720.840.030.040.03
Other Non Operating Income (Expenses)
8.12.35-0.031.71.030.72
EBT Excluding Unusual Items
27.4926.3138.6548.3842.6639
Other Unusual Items
0---18.42-9.6-
Pretax Income
28.0726.3138.6529.9633.0639
Income Tax Expense
7.058.8610.7311.689.999.96
Earnings From Continuing Operations
21.0317.4527.9218.2923.0729.04
Minority Interest in Earnings
-0.29-0.25-0.36-0.34-0.13-
Net Income
20.7317.227.5717.9422.9429.04
Net Income to Common
20.7317.227.5717.9422.9429.04
Net Income Growth
80.92%-37.59%53.63%-21.76%-21.03%30.10%
Shares Outstanding (Basic)
936939950766757-
Shares Outstanding (Diluted)
947950950766757-
Shares Change (YoY)
0.00%-24.00%1.19%--
EPS (Basic)
0.020.020.030.020.03-
EPS (Diluted)
0.020.020.030.020.03-
EPS Growth
82.97%-36.89%23.89%-22.68%--
Free Cash Flow
8.71-3.851.54-0.01-4.7216.63
Free Cash Flow Per Share
0.01-0.000.00--0.01-
Dividend Per Share
--0.0190.019--
Dividend Growth
--2.62%---
Gross Margin
36.79%40.31%54.72%45.72%35.86%33.61%
Operating Margin
13.72%15.38%24.80%26.92%19.99%21.17%
Profit Margin
14.05%11.05%17.66%10.13%10.87%15.75%
Free Cash Flow Margin
5.90%-2.47%0.99%-0.01%-2.23%9.01%
EBITDA
26.9430.5244.3451.8545.4641.26
EBITDA Margin
18.26%19.59%28.41%29.28%21.54%22.37%
D&A For EBITDA
6.76.565.644.173.282.21
EBIT
20.2423.9538.747.6842.1939.05
EBIT Margin
13.72%15.38%24.80%26.92%19.99%21.17%
Effective Tax Rate
25.10%33.67%27.76%38.97%30.22%25.54%
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.